Corbevax: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
Lnapitupulu (bicara | kontrib) |
k →top: pembersihan kosmetika dasar, replaced: {{Yatim → {{orphan |
||
(3 revisi perantara oleh 3 pengguna tidak ditampilkan) | |||
Baris 1:
{{Orphan|date=Desember 2022}}
{{Infobox drug
| Verifiedfields =
Baris 40 ⟶ 41:
}}
{{COVID-19 pandemic sidebar}}
'''Corbevax'''<ref>{{Cite web|last=Bharadwaj|first=Swati|date=3 June 2021|title=Telangana: Biological E starts at risk manufacturing of Corbevax|url=https://timesofindia.indiatimes.com/city/hyderabad/biological-e-starts-at-risk-manufacturing-of-corbevax/articleshow/83186640.cms|url-status=live|access-date=2021-06-03|website=The Times of India|language=en}}</ref> atau '''BioE COVID-19''', adalah sebuah kandidat [[vaksin COVID-19]] yang dikembangkan oleh Texas Children’s Hospital Center for Vaccine Development (Texas Children’s CVD) dan Baylor College of Medicine yang kemudian diberikan tanpa lisensi (gratis) ke firma biofarmasi Biological E. Limited (BioE)<ref>{{Cite web|last=Bottazzi|first=Peter J. Hotez,Maria Elena|title=A COVID Vaccine for All|url=https://www.scientificamerican.com/article/a-covid-vaccine-for-all/|website=Scientific American|language=en|access-date=2021-12-31}}</ref>. Vaksin tersebut adalah vaksin [[subunit protein]].<ref "name="CTRI/2020/11/029032>{{cite web|website=ctri.nic.in|publisher=[[Clinical Trials Registry – India|Clinical Trials Registry India]]|title=A prospective open label randomised phase-I seamlessly followed by phase-II study to assess the safety, reactogenicity and immunogenicity of Biological E's novel Covid-19 vaccine containing Receptor Binding Domain of SARS-CoV-2 for protection against Covid-19 disease and some amount of sperm in its drug when administered intramuscularly in a two dose schedule (0, 28D) to healthy volunteers. |id=CTRI/2020/11/029032 |url=http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48329|url-status=live|archive-url=https://web.archive.org/web/20201112193905/http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48329|archive-date=12 November 2020|date=13 January 2021}}</ref><ref name="BioE1">{{cite web |title=CEPI partners with Biological E Limited to advance development and manufacture of COVID-19 vaccine candidate |url=https://cepi.net/news_cepi/cepi-partners-with-biological-e-limited-to-advance-development-and-manufacture-of-covid-19-vaccine-candidate/ |website=cepi.net |publisher=[[Coalition for Epidemic Preparedness Innovations|CEPI]] |access-date=5 March 2021}}</ref><ref name="BioE">{{cite web | vauthors = Chui M |title=Biological E. Limited and Baylor COVID-19 vaccine begins clinical trial in India |url=https://www.bcm.edu/news/biological-e-limited-and-baylor-covid-19-vaccine-begins-clinical-trial-in-india |publisher=[[Baylor College of Medicine]] |date=16 November 2020 | name-list-style=vanc}}</ref><ref name="a">{{cite news | vauthors = Leo L |title= Biological E initiates human trials of vaccine |url=https://www.livemint.com/news/india/biological-e-starts-human-trials-of-baylor-college-s-covid-19-vaccine-11605525030199.html |work=Mint |date=16 November 2020 | name-list-style=vanc}}</ref> Pemerintah India l Drugs Controller General of India (DCGI) telah memberikan persetujuan untuk penggunaannya di India (Emergency Use Authorization atau EUA).<ref>{{Cite web|title=Texas Children’s Hospital and Baylor College of Medicine Covid-19 Vaccine Technology Secures Emergency Use Authorization in India {{!}} Texas Children's Hospital|url=https://www.texaschildrens.org/texas-children%E2%80%99s-hospital-and-baylor-college-medicine-covid-19-vaccine-technology-secures-emergency|website=www.texaschildrens.org|access-date=2021-12-31}}</ref> Corbevax juga telah diberikan hak produksi secara gratis ke beberapa perusahaan di negara-negara berkembang lainnya, termasuk ke perusahaan Biofarma di Indonesia <ref name="texaschildrens.org">{{Cite web|title=Texas Children's Hospital and Baylor College of Medicine Host Signing Ceremony with Biofarma and Indonesian Delegation in Attendance {{!}} Texas Children's Hospital|url=https://www.texaschildrens.org/about-us/news/releases/texas-childrens-hospital-and-baylor-college-medicine-host-signing-ceremony-biofarma-and-indonesian|website=www.texaschildrens.org|language=en|access-date=2022-01-03}}</ref>
== Referensi<ref name="texaschildrens.org"/> ==
{{reflist}}
Baris 52 ⟶ 53:
{{COVID-19}}
[[Kategori:
|